Dr SUZANNE MILLER suzanne.miller@nottingham.ac.uk
Senior Clinical Studies and Project Manager
The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis
Miller, Suzanne; Coveney, Clare; Johnson, Janice; Farmaki, Aliki Eleni; Gupta, Nishant; Tobin, Martin D.; Wain, Louise V.; McCormack, Francis X.; Boocock, David J.; Johnson, Simon R.
Authors
Clare Coveney
Janice Johnson
Aliki Eleni Farmaki
Nishant Gupta
Martin D. Tobin
Louise V. Wain
Francis X. McCormack
David J. Boocock
Professor SIMON JOHNSON simon.johnson@nottingham.ac.uk
PROFESSOR OF RESPIRATORY MEDICINE
Abstract
Background: Lymphangioleiomyomatosis (LAM) is a rare disease of women. Decline in lung function is variable making appropriate targeting of therapy difficult. We used unbiased serum proteomics to identify markers associated with outcome in LAM.
Methods: 101 women with LAM and 22 healthy controls were recruited from the National Centre for LAM (Nottingham, UK). 152 DNA and serum samples with linked lung function and outcome data were obtained from patients in the NHLBI LAM Registry (USA). Proteomic analysis was performed on a discovery cohort of 50 LAM and 20 control sera using a SCIEX SWATH mass spectrometric workflow. Protein levels were quantitated by ELISA and SNPs in GC encoding Vitamin D Binding Protein (VTDB) genotyped.
Results: Proteomic analysis showed VTDB was 2.6 fold lower in LAM than controls. Serum VTDB was lower in progressive compared with stable LAM (p=0.001) and correlated with diffusing capacity (p=0.01). Median time to death or lung transplant was reduced by 46 months in those with CC genotypes at rs4588 and 38 months in those with non-A containing haplotypes at rs7041/4588 (p=0.014 and 0.008 respectively).
Conclusions: The VTDB axis is associated with disease severity and outcome, and GC genotype could help predict transplant free survival in LAM.
Citation
Miller, S., Coveney, C., Johnson, J., Farmaki, A. E., Gupta, N., Tobin, M. D., Wain, L. V., McCormack, F. X., Boocock, D. J., & Johnson, S. R. (2018). The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis. European Respiratory Journal, 52(5), Article 1801074. https://doi.org/10.1183/13993003.00951-2018
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 29, 2018 |
Online Publication Date | Aug 9, 2018 |
Publication Date | Nov 1, 2018 |
Deposit Date | Nov 8, 2018 |
Publicly Available Date | Nov 8, 2018 |
Journal | European Respiratory Journal |
Print ISSN | 0903-1936 |
Electronic ISSN | 1399-3003 |
Publisher | European Respiratory Society |
Peer Reviewed | Peer Reviewed |
Volume | 52 |
Issue | 5 |
Article Number | 1801074 |
DOI | https://doi.org/10.1183/13993003.00951-2018 |
Keywords | Pulmonary and Respiratory Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/1183650 |
Publisher URL | https://erj.ersjournals.com/content/52/5/1800951 |
Contract Date | Nov 8, 2018 |
Files
ERJ-00951-2018
(621 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
OA (CCBY)
You might also like
Metagenomic changes in response to antibiotic treatment in severe orthopedic trauma patients
(2024)
Journal Article
Mast Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis
(2021)
Journal Article
Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search